← FDA DRUG APPROVALS

FDA NDA · NDA218579

ZYOGREEN

indocyanine green

Sponsor: PROVEPHARM SAS

APPLICATION
NDA218579
TYPE
NDA
ORIGINAL APPROVAL
2026-07-10
LATEST ACTION
2026-07-10
ROUTE
INTERSTITIAL, INTRAVENOUS, INTRAVENOUS, INTERSTITIAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

ZYOGREEN · ReferencePrescription
INDOCYANINE GREEN 25MG/10ML (2.5MG/ML) · SOLUTION · INTRAVENOUS, INTERSTITIAL

Approval history

2026-07-10Type 3 - New Dosage Form · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →